node1	node2	edge_score	
DB00002	FCGR2B	1.0	
DB00002	FCGR2A	1.0	
DB00002	C1QC	1.0	
DB00002	EGFR	1.0	
DB00002	C1QB	1.0	
DB00002	C1QA	1.0	
DB00002	FCGR2C	1.0	
DB00002	FCGR1A	1.0	
DB00002	C1S	1.0	
DB00002	C1R	1.0	
DB00002	FCGR3A	1.0	
DB00002	FCGR3B	1.0	
EGFR	rs712829	0.99
EGFR	rs2293347	0.99
FCGR2B		1.0
FCGR3A		1.0
FCGR2A		1.0
EGFR	rs712830	0.99
EGFR	rs121434569	0.99
EGFR	rs121434568	0.99
EGFR		1.0
UBC	TRAF6	0.863464374084
EGFR	rs11568315	0.99
EGFR	UBC	0.935012238275
EGFR	rs2227983	0.99
Giant cell arteritis	FCGR2A	1.0	
Giant cell arteritis	FCGR2B	1.0	
Giant cell arteritis	FCGR3A	1.0	
Giant cell arteritis	TRAF6	1.0	
Lupus Vulgaris	EGFR	1.0	
Lupus Vulgaris	FCGR2A	1.0	
Lupus Vulgaris	FCGR2B	1.0	
Lupus Vulgaris	FCGR3A	1.0	
Lupus Vulgaris	TRAF6	1.0	
Discoid lupus erythematosus	EGFR	1.0	
Discoid lupus erythematosus	FCGR2A	1.0	
Discoid lupus erythematosus	FCGR2B	1.0	
Discoid lupus erythematosus	FCGR3A	1.0	
Discoid lupus erythematosus	TRAF6	1.0	
Anti-Glomerular Basement Membrane Disease	FCGR2A	1.0	
Anti-Glomerular Basement Membrane Disease	FCGR2B	1.0	
Anti-Glomerular Basement Membrane Disease	FCGR3A	1.0	
Meningococcal Infections	FCGR2A	1.0	
Meningococcal Infections	FCGR2B	1.0	
Meningococcal Infections	FCGR3A	1.0	
{Systemic lupus erythematosus, susceptibility to, 8} (2)	EGFR	1.0	
{Systemic lupus erythematosus, susceptibility to, 8} (2)	FCGR2A	1.0	
{Systemic lupus erythematosus, susceptibility to, 8} (2)	FCGR2B	1.0	
{Systemic lupus erythematosus, susceptibility to, 8} (2)	FCGR3A	1.0	
{Systemic lupus erythematosus, susceptibility to, 8} (2)	TRAF6	1.0	
{Pemphigoid, susceptibility to} (2)	FCGR2A	1.0	
{Pemphigoid, susceptibility to} (2)	FCGR2B	1.0	
{Pemphigoid, susceptibility to} (2)	FCGR3A	1.0	
Lichen Planus, Oral	EGFR	1.0	
Lichen Planus, Oral	FCGR2A	1.0	
Lichen Planus, Oral	FCGR2B	1.0	
Recurrent bacterial infection	EGFR	1.0	
Recurrent bacterial infection	FCGR2A	1.0	
Recurrent bacterial infection	FCGR2B	1.0	
Recurrent bacterial infection	TRAF6	1.0	
Idiopathic thrombocytopenic purpura	FCGR2A	1.0	
Idiopathic thrombocytopenic purpura	FCGR2B	1.0	
Idiopathic thrombocytopenic purpura	FCGR3A	1.0	
Periodontal Attachment Loss	FCGR2A	1.0	
Periodontal Attachment Loss	FCGR3A	1.0	
Graft-versus-host disease, susceptibility to	EGFR	1.0	
Graft-versus-host disease, susceptibility to	FCGR2A	1.0	
Graft-versus-host disease, susceptibility to	FCGR3A	1.0	
Graft-versus-host disease, susceptibility to	TRAF6	1.0	
Neoplasm of the thymus	EGFR	1.0	
Neoplasm of the thymus	FCGR2A	1.0	
Common variable immunodeficiency 2	FCGR2A	1.0	
Common variable immunodeficiency 2	FCGR2B	1.0	
Common variable immunodeficiency 2	FCGR3A	1.0	
Hypohidrotic X-linked ectodermal dysplasia	EGFR	1.0	
Hypohidrotic X-linked ectodermal dysplasia	TRAF6	1.0	
Periodontal Pocket	FCGR2A	1.0	
Periodontal Pocket	FCGR3A	1.0	
Alveolar Bone Loss	FCGR2A	1.0	
Alveolar Bone Loss	FCGR3A	1.0	
Malignant neoplasm of brain and nervous system	EGFR	1.0	
Malignant neoplasm of brain and nervous system	FCGR2A	1.0	
Malignant neoplasm of brain and nervous system	FCGR3A	1.0	
Alveolar proteinosis	FCGR2A	1.0	
Alveolar proteinosis	FCGR2B	1.0	
Idiopathic crescentic glomerulonephritis	EGFR	1.0	
Idiopathic crescentic glomerulonephritis	FCGR3A	1.0	
Diffuse Scleroderma	FCGR2A	1.0	
Diffuse Scleroderma	FCGR3A	1.0	
Respiratory tract infection	EGFR	1.0	
Respiratory tract infection	FCGR2A	1.0	
Respiratory tract infection	FCGR2B	1.0	
Respiratory tract infection	FCGR3A	1.0	
Tumor necrosis	EGFR	1.0	
Tumor necrosis	FCGR3A	1.0	
Tumor necrosis	TRAF6	1.0	
Cachexia	EGFR	1.0	
Cachexia	TRAF6	1.0	
Cachexia	UBC	1.0	
Sickle Cell Trait	FCGR2A	1.0	
Sickle Cell Trait	FCGR2B	1.0	
Chronic Periodontitis	FCGR2A	1.0	
Chronic Periodontitis	FCGR2B	1.0	
Chronic Periodontitis	FCGR3A	1.0	
Lymphoma, Large B-Cell, Diffuse	EGFR	1.0	
Lymphoma, Large B-Cell, Diffuse	FCGR2A	1.0	
Lymphoma, Large B-Cell, Diffuse	FCGR2B	1.0	
Lymphoma, Large B-Cell, Diffuse	FCGR3A	1.0	
Lymphoma, Large B-Cell, Diffuse	TRAF6	1.0	
Lymphoma, Large B-Cell, Diffuse	UBC	1.0	
Pneumococcal Infections	FCGR2A	1.0	
Pneumococcal Infections	FCGR2B	1.0	
Guillain-Barre syndrome, familial	FCGR2A	1.0	
Guillain-Barre syndrome, familial	FCGR3A	1.0	
Pneumonitis	FCGR2A	1.0	
Pneumonitis	FCGR3A	1.0	
Mucocutaneous Lymph Node Syndrome	FCGR2A	1.0	
Mucocutaneous Lymph Node Syndrome	FCGR2B	1.0	
Mucocutaneous Lymph Node Syndrome	FCGR3A	1.0	
Infection by Cryptococcus neoformans	FCGR2A	1.0	
Infection by Cryptococcus neoformans	FCGR3A	1.0	
Tuberculosis, Pulmonary	EGFR	1.0	
Tuberculosis, Pulmonary	FCGR2A	1.0	
Tuberculosis, Pulmonary	FCGR3A	1.0	
Lupus Nephritis	FCGR2A	1.0	
Lupus Nephritis	FCGR2B	1.0	
Lupus Nephritis	FCGR3A	1.0	
{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)	FCGR2A	1.0	
{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)	FCGR2B	1.0	
Severe Dengue	FCGR2A	1.0	
Severe Dengue	FCGR2B	1.0	
Granulomatosis with Polyangiitis	FCGR2A	1.0	
Granulomatosis with Polyangiitis	FCGR3A	1.0	
Arthritis, Rheumatoid	EGFR	1.0	
Arthritis, Rheumatoid	FCGR2A	1.0	
Arthritis, Rheumatoid	FCGR2B	1.0	
Arthritis, Rheumatoid	FCGR3A	1.0	
Arthritis, Rheumatoid	TRAF6	1.0	
Neutropenia	FCGR2A	1.0	
Neutropenia	FCGR2B	1.0	
Neutropenia	FCGR3A	1.0	
Nephrotic syndrome, type 5, with or without ocular abnormalities	FCGR2A	1.0	
Nephrotic syndrome, type 5, with or without ocular abnormalities	FCGR2B	1.0	
Nephrotic syndrome, type 5, with or without ocular abnormalities	FCGR3A	1.0	
{Diphtheria, susceptibility to} (1)	EGFR	1.0	
{Diphtheria, susceptibility to} (1)	TRAF6	1.0	
Inflammatory disorder	FCGR2B	1.0	
Inflammatory disorder	FCGR3A	1.0	
Inflammatory disorder	TRAF6	1.0	
Candidiasis, familial, 9	FCGR2A	1.0	
Candidiasis, familial, 9	FCGR3A	1.0	
Recurrent upper respiratory tract infections	EGFR	1.0	
Recurrent upper respiratory tract infections	FCGR3A	1.0	
Parasitemia	FCGR2A	1.0	
Parasitemia	FCGR2B	1.0	
Periodontitis, Juvenile	FCGR2A	1.0	
Periodontitis, Juvenile	FCGR3A	1.0	
B-cell lymphoma	EGFR	1.0	
B-cell lymphoma	FCGR2A	1.0	
B-cell lymphoma	FCGR2B	1.0	
B-cell lymphoma	FCGR3A	1.0	
Merkel cell carcinoma	EGFR	1.0	
Merkel cell carcinoma	FCGR3A	1.0	
Acute Coronary Syndrome	EGFR	1.0	
Acute Coronary Syndrome	FCGR2A	1.0	
Acute Coronary Syndrome	FCGR3A	1.0	
Abnormality of the nasopharynx	EGFR	1.0	
Abnormality of the nasopharynx	FCGR3A	1.0	
Multiple Myeloma	EGFR	1.0	
Multiple Myeloma	FCGR2A	1.0	
Multiple Myeloma	FCGR2B	1.0	
Multiple Myeloma	FCGR3A	1.0	
Multiple Myeloma	TRAF6	1.0	
Periodontitis	FCGR2A	1.0	
Periodontitis	FCGR2B	1.0	
Periodontitis	FCGR3A	1.0	
Meningitis	FCGR2A	1.0	
Meningitis	FCGR3A	1.0	
Kidney Diseases	EGFR	1.0	
Kidney Diseases	FCGR2A	1.0	
Kidney Diseases	FCGR2B	1.0	
Kidney Diseases	FCGR3A	1.0	
Hepatitis, Autoimmune	FCGR2A	1.0	
Hepatitis, Autoimmune	FCGR2B	1.0	
Coronary Artery Disease	FCGR2A	1.0	
Coronary Artery Disease	FCGR2B	1.0	
Coronary Artery Disease	FCGR3A	1.0	
Coronary Artery Disease	TRAF6	1.0	
Coronary Artery Disease	UBC	1.0	
Abnormality of the pharynx	EGFR	1.0	
Abnormality of the pharynx	FCGR3A	1.0	
Lymphoma, Follicular	FCGR2A	1.0	
Lymphoma, Follicular	FCGR2B	1.0	
Lymphoma, Follicular	FCGR3A	1.0	
Urothelial Carcinoma	EGFR	1.0	
Urothelial Carcinoma	FCGR2A	1.0	
Urothelial Carcinoma	FCGR2B	1.0	
Gingival Diseases	FCGR2A	1.0	
Gingival Diseases	FCGR3A	1.0	
Pleural effusion	EGFR	1.0	
Pleural effusion	FCGR3A	1.0	
Rhinitis, Allergic, Seasonal	EGFR	1.0	
Rhinitis, Allergic, Seasonal	FCGR2A	1.0	
Lupus Erythematosus, Systemic	EGFR	1.0	
Lupus Erythematosus, Systemic	FCGR2A	1.0	
Lupus Erythematosus, Systemic	FCGR2B	1.0	
Lupus Erythematosus, Systemic	FCGR3A	1.0	
Lupus Erythematosus, Systemic	TRAF6	1.0	
Malaria, Falciparum	FCGR2A	1.0	
Malaria, Falciparum	FCGR2B	1.0	
Celiac Disease	EGFR	1.0	
Celiac Disease	FCGR2A	1.0	
Celiac Disease	FCGR3A	1.0	
Autoimmune disease 1	FCGR2A	1.0	
Autoimmune disease 1	FCGR2B	1.0	
Autoimmune disease 1	FCGR3A	1.0	
Autoimmune disease 1	TRAF6	1.0	
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	FCGR2A	1.0	
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	FCGR2B	1.0	
Progressive Neoplastic Disease	EGFR	1.0	
Progressive Neoplastic Disease	FCGR3A	1.0	
Progressive cGVHD	EGFR	1.0	
Progressive cGVHD	FCGR3A	1.0	
Drug Eruptions	EGFR	1.0	
Disorder of skeletal system	EGFR	1.0	
Papillary adenocarcinoma	EGFR	1.0	
Pleural Neoplasms	EGFR	1.0	
Sarcoma, Epithelioid	EGFR	1.0	
childhood rhabdomyosarcoma	EGFR	1.0	
Peritoneal Mesothelioma	EGFR	1.0	
Estrogen resistance	EGFR	1.0	
Pneumonia	EGFR	1.0	
Pneumonia	FCGR2A	1.0	
Pneumonia	FCGR3A	1.0	
Cervical dysplasia	EGFR	1.0	
Seborrheic keratosis	EGFR	1.0	
Dermatosis NOS	EGFR	1.0	
Dermatosis NOS	FCGR2A	1.0	
Dermatosis NOS	FCGR2B	1.0	
Adrenal Gland Hyperfunction	EGFR	1.0	
Dupuytren Contracture	EGFR	1.0	
Multiple Endocrine Neoplasia Type 2b	EGFR	1.0	
Breast cancer recurrent	EGFR	1.0	
Early gastric cancer	EGFR	1.0	
Malignant neoplasm of vulva	EGFR	1.0	
Astrocytoma, low grade	EGFR	1.0	
Thymoma	EGFR	1.0	
Thymoma	FCGR2A	1.0	
Nephritis	FCGR2A	1.0	
Nephritis	FCGR3A	1.0	
Pyruvate carboxylase deficiency	EGFR	1.0	
Squamous Cell Neoplasms	EGFR	1.0	
Pituitary dependent hypercortisolism	EGFR	1.0	
Dermatofibrosarcoma protuberans	EGFR	1.0	
Familial cold-induced inflammatory syndrome 1, 120100 (3)	EGFR	1.0	
Bacterial endocarditis	FCGR2A	1.0	
Recurrent bronchitis	EGFR	1.0	
Large cell neuroendocrine carcinoma	EGFR	1.0	
Thymic Carcinoma	EGFR	1.0	
Myeloproliferative disorder, chronic, with eosinophilia	EGFR	1.0	
Vasculitis	FCGR2A	1.0	
Vasculitis	FCGR2B	1.0	
Hypersensitivity	EGFR	1.0	
Hypersensitivity	TRAF6	1.0	
Monocytosis	FCGR2B	1.0	
Gastrinoma	EGFR	1.0	
Puerperal Disorders	FCGR2A	1.0	
Xeroderma Pigmentosum, Complementation Group D	EGFR	1.0	
Recurrent sinusitis	FCGR3A	1.0	
TNF receptor-associated periodic fever syndrome (TRAPS)	FCGR3A	1.0	
Herpes Simplex Infections	EGFR	1.0	
Herpes Simplex Infections	FCGR2B	1.0	
Herpes Simplex Infections	FCGR3A	1.0	
Staphylococcal Infections	EGFR	1.0	
Stage IV Ovarian Carcinoma	EGFR	1.0	
Adenocarcinoma in Situ	EGFR	1.0	
Anterior myocardial infarction	FCGR3A	1.0	
Complete hydatidiform mole	EGFR	1.0	
Mucinous Neoplasm	EGFR	1.0	
Primary Lesion	EGFR	1.0	
Pericardial effusion	EGFR	1.0	
Rheumatic fever / chorea	FCGR2A	1.0	
Malignant neoplasm of oropharynx	EGFR	1.0	
Acinar Cell Carcinoma	EGFR	1.0	
Comedone	EGFR	1.0	
Prostate cancer recurrent	EGFR	1.0	
Sentinel node (disorder)	EGFR	1.0	
Malaria	FCGR2A	1.0	
Malaria	FCGR2B	1.0	
Malaria	FCGR3A	1.0	
Acute myeloid leukemia	EGFR	1.0	
Acute myeloid leukemia	FCGR2A	1.0	
Acute myeloid leukemia	FCGR2B	1.0	
Acute myeloid leukemia	FCGR3A	1.0	
Acute myeloid leukemia	TRAF6	1.0	
Severe combined immunodeficiency due to ADA deficiency	EGFR	1.0	
Severe combined immunodeficiency due to ADA deficiency	FCGR3A	1.0	
Severe combined immunodeficiency due to ADA deficiency	TRAF6	1.0	
Endocarditis	FCGR2A	1.0	
Arthritis, Psoriatic	FCGR2A	1.0	
Arthritis, Psoriatic	FCGR3A	1.0	
Neoplasm of the peripheral nervous system	EGFR	1.0	
Polymyalgia Rheumatica	TRAF6	1.0	
Hemangioblastoma	EGFR	1.0	
Metastatic Carcinoma	EGFR	1.0	
Microscopic Polyarteritis	FCGR2A	1.0	
Non-Hodgkin lymphoma	FCGR2A	1.0	
Non-Hodgkin lymphoma	FCGR3A	1.0	
Non-Hodgkin lymphoma	TRAF6	1.0	
Myasthenia Gravis	FCGR2A	1.0	
Myasthenia Gravis	FCGR3A	1.0	
Allergic disposition	FCGR2A	1.0	
Allergic disposition	FCGR2B	1.0	
Autoimmune hemolytic anemia	FCGR3A	1.0	
Community acquired pneumonia	FCGR2A	1.0	
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	FCGR2A	1.0	
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	FCGR3A	1.0	
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	TRAF6	1.0	
Herpesviridae Infections	FCGR3A	1.0	
Malignant neoplasm of stomach stage IV	EGFR	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	EGFR	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	FCGR2A	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	FCGR3A	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	TRAF6	1.0	
Diffuse Astrocytoma	EGFR	1.0	
Intracranial glioma	EGFR	1.0	
Testicular seminoma	EGFR	1.0	
Testicular seminoma	UBC	1.0	
Plague	EGFR	1.0	
Neurofibromatoses	EGFR	1.0	
Stromal sarcoma	EGFR	1.0	
Clear cell sarcoma, of tendons and aponeuroses	EGFR	1.0	
Rhinovirus infection	EGFR	1.0	
Pneumonia, Bacterial	FCGR2A	1.0	
Bronchogenic Carcinoma	EGFR	1.0	
Neuromyelitis Optica	FCGR3A	1.0	
CNS metastases	EGFR	1.0	
Chronic rejection of renal transplant	EGFR	1.0	
Otitis media	FCGR2A	1.0	
Otitis media	FCGR3A	1.0	
Rheumatoid arthritis	EGFR	1.0	
Rheumatoid arthritis	FCGR2A	1.0	
Rheumatoid arthritis	FCGR2B	1.0	
Rheumatoid arthritis	FCGR3A	1.0	
Rheumatoid arthritis	TRAF6	1.0	
Carcinosarcoma	EGFR	1.0	
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	EGFR	1.0	
Erythroblastosis	EGFR	1.0	
Primary malignant neoplasm of brain	EGFR	1.0	
Gestational trophoblastic disease	EGFR	1.0	
Sepsis	FCGR2A	1.0	
Sepsis	FCGR3A	1.0	
Sepsis	TRAF6	1.0	
Anaphylactic shock NOS	FCGR2A	1.0	
Cholesteatoma	EGFR	1.0	
Malignant neoplasm of male breast	EGFR	1.0	
Chloracne	EGFR	1.0	
Dryness of eye	EGFR	1.0	
Tumor-Associated Vasculature	EGFR	1.0	
Nasal polyposis	EGFR	1.0	
Nasal polyposis	TRAF6	1.0	
Ovarian Diseases	FCGR2A	1.0	
Ovarian Diseases	FCGR2B	1.0	
Gastritis	EGFR	1.0	
Gastritis	FCGR3A	1.0	
Single tumor	EGFR	1.0	
Primary Carcinoma	EGFR	1.0	
Symptomatic human immunodeficiency virus infection	EGFR	1.0	
Symptomatic human immunodeficiency virus infection	FCGR2A	1.0	
Symptomatic human immunodeficiency virus infection	FCGR2B	1.0	
Symptomatic human immunodeficiency virus infection	FCGR3A	1.0	
Symptomatic human immunodeficiency virus infection	TRAF6	1.0	
Chronic Lymphocytic Leukemia	EGFR	1.0	
Chronic Lymphocytic Leukemia	FCGR2A	1.0	
Chronic Lymphocytic Leukemia	FCGR2B	1.0	
Chronic Lymphocytic Leukemia	FCGR3A	1.0	
Mycoses	FCGR2A	1.0	
Mycoses	TRAF6	1.0	
Yolk Sac Tumor	EGFR	1.0	
Autosomal recessive polycystic kidney disease	EGFR	1.0	
Acute intermittent porphyria	EGFR	1.0	
Ganglioglioma	EGFR	1.0	
Oropharyngeal disorders	EGFR	1.0	
Recurrent pneumonia	EGFR	1.0	
Mammary Carcinoma, Human	EGFR	1.0	
Pituitary corticotropic cell adenoma	EGFR	1.0	
Dry Eye Syndromes	EGFR	1.0	
Neoplasm of the respiratory system	EGFR	1.0	
Takayasu Arteritis	FCGR2A	1.0	
Adenosquamous carcinoma	EGFR	1.0	
CARCINOMA OF VULVA	EGFR	1.0	
Brucellosis	FCGR2A	1.0	
Streptococcal Infections	FCGR2A	1.0	
Li-Fraumeni syndrome	EGFR	1.0	
Varicella zoster	FCGR3A	1.0	
Neck Neoplasms	EGFR	1.0	
Squamous cell carcinoma of mouth	EGFR	1.0	
Bile duct cancer resectable	EGFR	1.0	
Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	FCGR2A	1.0	
Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	FCGR3A	1.0	
Inflammation	EGFR	1.0	
Inflammation	FCGR2A	1.0	
Inflammation	FCGR3A	1.0	
IgA nephropathy, susceptibility to, 3	FCGR2A	1.0	
IgA nephropathy, susceptibility to, 3	FCGR2B	1.0	
IgA nephropathy, susceptibility to, 3	FCGR3A	1.0	
Neoplasm of the gallbladder	EGFR	1.0	
Rous Sarcoma	UBC	1.0	
Ganglioneuroblastoma	EGFR	1.0	
Papillomavirus Infections	EGFR	1.0	
stage, non-small cell lung cancer	EGFR	1.0	
Phyllodes tumor, benign	EGFR	1.0	
Uterine Cancer	EGFR	1.0	
Trichomegaly	EGFR	1.0	
Peptic Esophagitis	EGFR	1.0	
Leukoplakia	EGFR	1.0	
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	FCGR2B	1.0	
Neurofibromas	EGFR	1.0	
Recurrent lower respiratory tract infections	EGFR	1.0	
Colitis, Ulcerative	EGFR	1.0	
Colitis, Ulcerative	FCGR2A	1.0	
Colitis, Ulcerative	TRAF6	1.0	
Atherosclerosis	EGFR	1.0	
Atherosclerosis	FCGR2A	1.0	
Atherosclerosis	FCGR3A	1.0	
Atherosclerosis	TRAF6	1.0	
pathologic fistula	EGFR	1.0	
Nerve Sheath Tumors	EGFR	1.0	
Brain Tumor, Primary	EGFR	1.0	
Low Grade Squamous Intraepithelial Neoplasia	EGFR	1.0	
Leukemia, Large Granular Lymphocytic	FCGR3A	1.0	
Chromosome Xq28 deletion syndrome	EGFR	1.0	
Carcinoma, Neuroendocrine	EGFR	1.0	
Carcinoma of Male Breast	EGFR	1.0	
Neoplasm Recurrence, Local	EGFR	1.0	
Neoplasm Recurrence, Local	FCGR2A	1.0	
Arnold-Chiari malformation	EGFR	1.0	
Russell-Silver syndrome	EGFR	1.0	
Biliary tract neoplasm	EGFR	1.0	
Optic neuropathy	EGFR	1.0	
Female pseudohermaphroditism	EGFR	1.0	
Malignant Fibrous Histiocytoma	EGFR	1.0	
Human papilloma virus infection	EGFR	1.0	
EPIDERMODYSPLASIA VERRUCIFORMIS	FCGR3A	1.0	
Oropharyngeal squamous cell carcinoma	EGFR	1.0	
Lymphangiomyomatosis	EGFR	1.0	
